Tong Ren Tang Technologies Co (HKSE:01666) 3-Year Book Growth Rate : 3.50% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Tong Ren Tang Technologies Co 3-Year Book Growth Rate?

Tong Ren Tang Technologies Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$5.88.

During the past 12 months, Tong Ren Tang Technologies Co's average Book Value per Share Growth Rate was 4.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 3.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 4.90% per year. During the past 10 years, the average Book Value per Share Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Tong Ren Tang Technologies Co was 59.60% per year. The lowest was 3.40% per year. And the median was 11.95% per year.

Competitive Comparison of Tong Ren Tang Technologies Co's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tong Ren Tang Technologies Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Tong Ren Tang Technologies Co's 3-Year Book Growth Rate falls into.

Tong Ren Tang Technologies Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Tong Ren Tang Technologies Co (HKSE:01666) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Tong Ren Tang Technologies Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Tong Ren Tang Technologies Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Tong Ren Tang Technologies Co (HKSE:01666) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tong Ren Tang Technologies Co Ltd (HKSE:01666) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

TGRNF:USA TNG:Germany

Address

No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN

Website

https://www.tongrentangkj.com

Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and primarily operates in Mainland China and Hong Kong. The operating segments derive their revenue primarily from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.

Executives

Citigroup Inc.	2502 Approved lending agent
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Aberdeen Asset Management Plc And Its Associates	2102 Investment manager

Tong Ren Tang Technologies Co (HKSE:01666) Headlines

No Headlines